Automated Mucormycosis Diagnosis from Paranasal CT Using ResNet50 and ConvNeXt Small.
Automated mucormycosis diagnosis via CT scans shows 100% accuracy with ConvNeXt Small model. π€π¦
September 1, 2025
Follow us
latest articles
Discover the newest research about AI innovations in π§ͺ Pathology.
ProMUS-NET: Artificial intelligence detects more prostate cancer than urologists on micro-ultrasonography.
AI surpasses urologists in prostate cancer detection on micro-ultrasonography: 73% vs 58% sensitivity. ππ€
August 27, 2025
Reshaping Organizational Culture in Pathology.
“Transforming Pathology Culture: Emphasizing collaboration, AI, and diversity for enhanced diagnostic accuracy and team growth. ππ€”
August 17, 2025
Implication of Bimodal Magnetic Resonance and Fluorescence Imaging Probes in Advanced Healthcare: Enhancing Disease Diagnosis and Targeted Therapy.
Bimodal imaging probes enhance disease diagnosis and therapy, combining MRI and fluorescence for improved precision. π§¬π¬
August 4, 2025
Automating Colon Polyp Classification in Digital Pathology by Evaluation of a “Machine Learning as a Service” AI Model: Algorithm Development and Validation Study.
AI in Colon Polyp Classification: 100% Accuracy Achieved! π€π
August 1, 2025
AI Model Enhances Tumor Detection in Breast MRI
AI model improves tumor detection in breast MRI, enhancing accuracy and efficiency for better cancer screening. π©Ίπ
July 28, 2025
AI Enhances Pathologists’ Analysis of Skin Cancer Tissue Samples
AI improves pathologists’ analysis of skin cancer tissue samples, enhancing consistency and accuracy in patient prognoses. π©Ίπ
July 21, 2025
AI Enhances Cancer Treatment Matching for Pathologists
AI improves cancer treatment matching for pathologists, enhancing tumor sample analysis and potentially reducing genetic testing needs. π§¬π»
July 20, 2025
Sora Neuroscience’s Cirrus Brain Mapping Software Receives FDA Approval
Sora Neuroscience’s Cirrus brain mapping software has received FDA approval, aiding neurosurgeons in surgical planning. π§ β
June 30, 2025
Personalized translational medicine: Investigating YKL-40 as early biomarker for clinical risk stratification in hepatocellular carcinoma recurrence post-liver transplantation.
YKL-40 shows promise as a biomarker for HCC recurrence post-liver transplantation, enhancing risk stratification. ππ
June 19, 2025